Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells (Q44036647)

29 November 2017

Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells (English)

1 reference

29 November 2017

mesenchymal stem cell

1 reference

1 reference

Lingling Hou

1

1 reference

29 November 2017

Xiaoyu Wang

2

1 reference

29 November 2017

Yaqiong Zhou

3

1 reference

29 November 2017

Haibin Ma

4

1 reference

29 November 2017

Ziling Wang

5

1 reference

29 November 2017

Jinsheng He

6

1 reference

29 November 2017

Honggang Hu

7

1 reference

29 November 2017

Weijun Guan

8

1 reference

29 November 2017

Yuehui Ma

9

1 reference

29 November 2017

18 October 2013

1 reference

29 November 2017

1 reference

29 November 2017

35

1 reference

29 November 2017

1239-1250

1 reference

29 November 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-1165-5

29 November 2017

0 references

cites work

Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Cytotoxicity of rat marrow stromal cells against malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Wnt signaling: is the party in the nucleus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Wnt signalling in stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

NOTCH signaling as a novel cancer therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Notch signalling regulates stem cell numbers in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

APC dosage effects in tumorigenesis and stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Wnt signaling regulates the invasion capacity of human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Influence of prostaglandin A2 on Bax, Bcl-2 and PCNA expression in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Advances in mesenchymal stem cell-mediated gene therapy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

The uncertain role of unmodified mesenchymal stem cells in tumor progression: what master switch?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Mesenchymal stem cells engineered for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Tissue-resident stem cells promote breast cancer growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1165-5

Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice

21 January 2018

1 reference

12 December 2020

Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells.

1 reference

12 December 2020

Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice

1 reference

12 December 2020

Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction

1 reference

12 December 2020

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

12 December 2020

10.1007/S13277-013-1165-5

Identifiers

DOI

1 reference

29 November 2017

1 reference